Archimedic Blog

Neglected…thy name is Reimbursement.

"We'll figure out reimbursement after we get a prototype," is a common sentence in MedTech, but it can also be one of the most expensive.

I get it. Early-stage c...

I had the privilege of interviewing the Value Analysis Whisperer himself, Mark Copeland, who cracked open the black box of Value Analysis Committees and shared the secrets that MedTech companies need ...

You’ve probably heard of Proteus.  mAt one time it was the darling of digital health. But within a single year, Proteus went from a $1.5B valuation to a fire sale at $15m. Here's a recreation of event...